APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

T Cell Surface Glycoprotein CD4

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global T Cell Surface Glycoprotein CD4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174039420319 December 2025180 pages

Choose your research edition.

Industry ResearchT Cell Surface Glycoprotein CD4 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal T Cell Surface Glycoprotein CD4 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal T Cell Surface Glycoprotein CD4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Cell Surface Glycoprotein CD4 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal T Cell Surface Glycoprotein CD4 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global T Cell Surface Glycoprotein CD4 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for T Cell Surface Glycoprotein CD4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for T Cell Surface Glycoprotein CD4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for T Cell Surface Glycoprotein CD4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for T Cell Surface Glycoprotein CD4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of T Cell Surface Glycoprotein CD4 include Sanofi, United Biomedical Inc, Bristol-Myers Squibb Co, TaiMed Biologics Inc, Immupharma Plc, Fountain Biopharma Inc, CEL-SCI Corp and Biotest AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global T Cell Surface Glycoprotein CD4 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of T Cell Surface Glycoprotein CD4 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents T Cell Surface Glycoprotein CD4 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the T Cell Surface Glycoprotein CD4 market size, projected growth trends, production technologies, key applications, and end-use industries.

T Cell Surface Glycoprotein CD4 Segment by Company

Sanofi

United Biomedical Inc

Bristol-Myers Squibb Co

TaiMed Biologics Inc

Immupharma Plc

Fountain Biopharma Inc

CEL-SCI Corp

Biotest AG

T Cell Surface Glycoprotein CD4 Segment by Type

Forigerimod Acetate

Ibalizumab

HIV Vaccine 2

Others

T Cell Surface Glycoprotein CD4 Segment by Application

HIV

GVHD

SARS

AIDS

Others

T Cell Surface Glycoprotein CD4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Cell Surface Glycoprotein CD4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Cell Surface Glycoprotein CD4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Cell Surface Glycoprotein CD4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the T Cell Surface Glycoprotein CD4 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of T Cell Surface Glycoprotein CD4 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of T Cell Surface Glycoprotein CD4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of T Cell Surface Glycoprotein CD4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. T Cell Surface Glycoprotein CD4 Industry Trends Table 2. T Cell Surface Glycoprotein CD4 Industry Drivers Table 3. T Cell Surface Glycoprotein CD4 Industry Opportunities and Challenges Table 4. T Cell Surface Glycoprotein CD4 Industry Restraints Table 5. Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global T Cell Surface Glycoprotein CD4 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Manufacturers Table 9. Global T Cell Surface Glycoprotein CD4 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global T Cell Surface Glycoprotein CD4 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global T Cell Surface Glycoprotein CD4 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global T Cell Surface Glycoprotein CD4 Manufacturers, Product Type & Application Table 13. Global T Cell Surface Glycoprotein CD4 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global T Cell Surface Glycoprotein CD4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Forigerimod Acetate Table 17. Major Manufacturers of Ibalizumab Table 18. Major Manufacturers of HIV Vaccine 2 Table 19. Major Manufacturers of Others Table 20. Global T Cell Surface Glycoprotein CD4 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Units) Table 22. Global T Cell Surface Glycoprotein CD4 Sales by Type (2027-2032) & (K Units) Table 23. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2021-2026) Table 24. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2027-2032) Table 25. Global T Cell Surface Glycoprotein CD4 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2021-2026) & (K Units) Table 27. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2027-2032) & (K Units) Table 28. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2021-2026) Table 29. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of HIV Table 31. Major Manufacturers of GVHD Table 32. Major Manufacturers of SARS Table 33. Major Manufacturers of AIDS Table 34. Major Manufacturers of Others Table 35. Global T Cell Surface Glycoprotein CD4 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Units) Table 37. Global T Cell Surface Glycoprotein CD4 Sales by Application (2027-2032) & (K Units) Table 38. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2021-2026) Table 39. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2027-2032) Table 40. Global T Cell Surface Glycoprotein CD4 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2021-2026) & (K Units) Table 42. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2027-2032) & (K Units) Table 43. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2021-2026) Table 44. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2027-2032) Table 45. Global T Cell Surface Glycoprotein CD4 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global T Cell Surface Glycoprotein CD4 Sales by Region (2021-2026) & (K Units) Table 47. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2021-2026) Table 48. Global T Cell Surface Glycoprotein CD4 Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global T Cell Surface Glycoprotein CD4 Sales Forecasted Market Share by Region (2027-2032) Table 50. North America T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Units) Table 52. North America T Cell Surface Glycoprotein CD4 Sales by Country (2027-2032) & (K Units) Table 53. Europe T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Units) Table 55. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2027-2032) & (K Units) Table 62. Global T Cell Surface Glycoprotein CD4 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global T Cell Surface Glycoprotein CD4 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global T Cell Surface Glycoprotein CD4 Revenue by Region (2027-2032) & (US$ Million) Table 65. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2021-2026) Table 66. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2027-2032) Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sanofi T Cell Surface Glycoprotein CD4 Product Portfolio Table 71. Sanofi Recent Development Table 72. United Biomedical Inc Company Information Table 73. United Biomedical Inc Business Overview Table 74. United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. United Biomedical Inc T Cell Surface Glycoprotein CD4 Product Portfolio Table 76. United Biomedical Inc Recent Development Table 77. Bristol-Myers Squibb Co Company Information Table 78. Bristol-Myers Squibb Co Business Overview Table 79. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product Portfolio Table 81. Bristol-Myers Squibb Co Recent Development Table 82. TaiMed Biologics Inc Company Information Table 83. TaiMed Biologics Inc Business Overview Table 84. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product Portfolio Table 86. TaiMed Biologics Inc Recent Development Table 87. Immupharma Plc Company Information Table 88. Immupharma Plc Business Overview Table 89. Immupharma Plc T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Immupharma Plc T Cell Surface Glycoprotein CD4 Product Portfolio Table 91. Immupharma Plc Recent Development Table 92. Fountain Biopharma Inc Company Information Table 93. Fountain Biopharma Inc Business Overview Table 94. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product Portfolio Table 96. Fountain Biopharma Inc Recent Development Table 97. CEL-SCI Corp Company Information Table 98. CEL-SCI Corp Business Overview Table 99. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product Portfolio Table 101. CEL-SCI Corp Recent Development Table 102. Biotest AG Company Information Table 103. Biotest AG Business Overview Table 104. Biotest AG T Cell Surface Glycoprotein CD4 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Biotest AG T Cell Surface Glycoprotein CD4 Product Portfolio Table 106. Biotest AG Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. T Cell Surface Glycoprotein CD4 Distributors List Table 110. T Cell Surface Glycoprotein CD4 Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. T Cell Surface Glycoprotein CD4 Product Image Figure 2. Global T Cell Surface Glycoprotein CD4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global T Cell Surface Glycoprotein CD4 Market Size (2021-2032) & (US$ Million) Figure 4. Global T Cell Surface Glycoprotein CD4 Sales (2021-2032) & (K Units) Figure 5. Global T Cell Surface Glycoprotein CD4 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 T Cell Surface Glycoprotein CD4 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Forigerimod Acetate Image Figure 9. Ibalizumab Image Figure 10. HIV Vaccine 2 Image Figure 11. Others Image Figure 12. Global T Cell Surface Glycoprotein CD4 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global T Cell Surface Glycoprotein CD4 Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2021-2032) Figure 15. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global T Cell Surface Glycoprotein CD4 Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2021-2032) Figure 18. HIV Image Figure 19. GVHD Image Figure 20. SARS Image Figure 21. AIDS Image Figure 22. Others Image Figure 23. Global T Cell Surface Glycoprotein CD4 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global T Cell Surface Glycoprotein CD4 Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2021-2032) Figure 26. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global T Cell Surface Glycoprotein CD4 Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2021-2032) Figure 29. North America T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2021-2032) Figure 31. U.S. T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2021-2032) Figure 36. Germany T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2021-2032) Figure 43. China T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2021-2032) Figure 51. Brazil T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile T Cell Surface Glycoprotein CD4 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global T Cell Surface Glycoprotein CD4 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America T Cell Surface Glycoprotein CD4 Revenue (2021-2032) & (US$ Million) Figure 62. North America T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe T Cell Surface Glycoprotein CD4 Revenue (2021-2032) & (US$ Million) Figure 64. Europe T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. T Cell Surface Glycoprotein CD4 Value Chain Figure 70. Manufacturing Cost Structure Figure 71. T Cell Surface Glycoprotein CD4 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Forigerimod Acetate
  • Ibalizumab
  • HIV Vaccine 2
  • Others
Applications
  • HIV
  • GVHD
  • SARS
  • AIDS
  • Others
Companies covered
  • Sanofi
  • United Biomedical Inc
  • Bristol-Myers Squibb Co
  • TaiMed Biologics Inc
  • Immupharma Plc
  • Fountain Biopharma Inc
  • CEL-SCI Corp
  • Biotest AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global T Cell Surface Glycoprotein CD4 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global T Cell Surface Glycoprotein CD4 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global T Cell Surface Glycoprotein CD4 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global T Cell Surface Glycoprotein CD4 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global T Cell Surface Glycoprotein CD4 Market Dynamics
  1. 2.1 T Cell Surface Glycoprotein CD4 Industry Trends
  2. 2.2 T Cell Surface Glycoprotein CD4 Industry Drivers
  3. 2.3 T Cell Surface Glycoprotein CD4 Industry Opportunities and Challenges
  4. 2.4 T Cell Surface Glycoprotein CD4 Industry Restraints
3 T Cell Surface Glycoprotein CD4 Market by Manufacturers
  1. 3.1 Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global T Cell Surface Glycoprotein CD4 Sales by Manufacturers (2021-2026)
  3. 3.3 Global T Cell Surface Glycoprotein CD4 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global T Cell Surface Glycoprotein CD4 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global T Cell Surface Glycoprotein CD4 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global T Cell Surface Glycoprotein CD4 Manufacturers, Product Type & Application
  7. 3.7 Global T Cell Surface Glycoprotein CD4 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global T Cell Surface Glycoprotein CD4 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 T Cell Surface Glycoprotein CD4 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 T Cell Surface Glycoprotein CD4 Tier 1, Tier 2, and Tier 3
4 T Cell Surface Glycoprotein CD4 Market by Type
  1. 4.1 T Cell Surface Glycoprotein CD4 Type Introduction
  2. 4.1.1 Forigerimod Acetate
  3. 4.1.2 Ibalizumab
  4. 4.1.3 HIV Vaccine 2
  5. 4.1.4 Others
  6. 4.2 Global T Cell Surface Glycoprotein CD4 Sales by Type
  7. 4.2.1 Global T Cell Surface Glycoprotein CD4 Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global T Cell Surface Glycoprotein CD4 Sales by Type (2021-2032)
  9. 4.2.3 Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2021-2032)
  10. 4.3 Global T Cell Surface Glycoprotein CD4 Revenue by Type
  11. 4.3.1 Global T Cell Surface Glycoprotein CD4 Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global T Cell Surface Glycoprotein CD4 Revenue by Type (2021-2032)
  13. 4.3.3 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2021-2032)
5 T Cell Surface Glycoprotein CD4 Market by Application
  1. 5.1 T Cell Surface Glycoprotein CD4 Application Introduction
  2. 5.1.1 HIV
  3. 5.1.2 GVHD
  4. 5.1.3 SARS
  5. 5.1.4 AIDS
  6. 5.1.5 Others
  7. 5.2 Global T Cell Surface Glycoprotein CD4 Sales by Application
  8. 5.2.1 Global T Cell Surface Glycoprotein CD4 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global T Cell Surface Glycoprotein CD4 Sales by Application (2021-2032)
  10. 5.2.3 Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2021-2032)
  11. 5.3 Global T Cell Surface Glycoprotein CD4 Revenue by Application
  12. 5.3.1 Global T Cell Surface Glycoprotein CD4 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global T Cell Surface Glycoprotein CD4 Revenue by Application (2021-2032)
  14. 5.3.3 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2021-2032)
6 Global T Cell Surface Glycoprotein CD4 Sales by Region
  1. 6.1 Global T Cell Surface Glycoprotein CD4 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global T Cell Surface Glycoprotein CD4 Sales by Region (2021-2032)
  3. 6.2.1 Global T Cell Surface Glycoprotein CD4 Sales by Region (2021-2026)
  4. 6.2.2 Global T Cell Surface Glycoprotein CD4 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America T Cell Surface Glycoprotein CD4 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe T Cell Surface Glycoprotein CD4 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global T Cell Surface Glycoprotein CD4 Revenue by Region
  1. 7.1 Global T Cell Surface Glycoprotein CD4 Revenue by Region
  2. 7.1.1 Global T Cell Surface Glycoprotein CD4 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global T Cell Surface Glycoprotein CD4 Revenue by Region (2021-2026)
  4. 7.1.3 Global T Cell Surface Glycoprotein CD4 Revenue by Region (2027-2032)
  5. 7.1.4 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America T Cell Surface Glycoprotein CD4 Revenue (2021-2032)
  8. 7.2.2 North America T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe T Cell Surface Glycoprotein CD4 Revenue (2021-2032)
  11. 7.3.2 Europe T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi T Cell Surface Glycoprotein CD4 Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 United Biomedical Inc
  8. 8.2.1 United Biomedical Inc Company Information
  9. 8.2.2 United Biomedical Inc Business Overview
  10. 8.2.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 United Biomedical Inc T Cell Surface Glycoprotein CD4 Product Portfolio
  12. 8.2.5 United Biomedical Inc Recent Developments
  13. 8.3 Bristol-Myers Squibb Co
  14. 8.3.1 Bristol-Myers Squibb Co Company Information
  15. 8.3.2 Bristol-Myers Squibb Co Business Overview
  16. 8.3.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Co Recent Developments
  19. 8.4 TaiMed Biologics Inc
  20. 8.4.1 TaiMed Biologics Inc Company Information
  21. 8.4.2 TaiMed Biologics Inc Business Overview
  22. 8.4.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product Portfolio
  24. 8.4.5 TaiMed Biologics Inc Recent Developments
  25. 8.5 Immupharma Plc
  26. 8.5.1 Immupharma Plc Company Information
  27. 8.5.2 Immupharma Plc Business Overview
  28. 8.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Immupharma Plc T Cell Surface Glycoprotein CD4 Product Portfolio
  30. 8.5.5 Immupharma Plc Recent Developments
  31. 8.6 Fountain Biopharma Inc
  32. 8.6.1 Fountain Biopharma Inc Company Information
  33. 8.6.2 Fountain Biopharma Inc Business Overview
  34. 8.6.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product Portfolio
  36. 8.6.5 Fountain Biopharma Inc Recent Developments
  37. 8.7 CEL-SCI Corp
  38. 8.7.1 CEL-SCI Corp Company Information
  39. 8.7.2 CEL-SCI Corp Business Overview
  40. 8.7.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product Portfolio
  42. 8.7.5 CEL-SCI Corp Recent Developments
  43. 8.8 Biotest AG
  44. 8.8.1 Biotest AG Company Information
  45. 8.8.2 Biotest AG Business Overview
  46. 8.8.3 Biotest AG T Cell Surface Glycoprotein CD4 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biotest AG T Cell Surface Glycoprotein CD4 Product Portfolio
  48. 8.8.5 Biotest AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 T Cell Surface Glycoprotein CD4 Value Chain Analysis
  2. 9.1.1 T Cell Surface Glycoprotein CD4 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 T Cell Surface Glycoprotein CD4 Production Mode & Process
  6. 9.2 T Cell Surface Glycoprotein CD4 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 T Cell Surface Glycoprotein CD4 Distributors
  9. 9.2.3 T Cell Surface Glycoprotein CD4 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst